HCA250117C250000
- 57.50
- 0.000.00%
HCA Healthcare Newsroom
Morgan Stanley Maintains HCA Healthcare(HCA.US) With Hold Rating, Maintains Target Price $355
Cautious Hold Rating on HCA Healthcare Amid Policy Uncertainties and Market Fluctuations
HCA Healthcare Is Maintained at Overweight by Keybanc
HCA Healthcare Analyst Ratings
KeyBanc Maintains HCA Healthcare(HCA.US) With Buy Rating, Cuts Target Price to $370
Truist Financial Maintains HCA Healthcare(HCA.US) With Buy Rating, Announces Target Price $390
HCA Healthcare Analyst Ratings
Truist Securities Maintains Buy on HCA Healthcare, Lowers Price Target to $390
Optimistic Outlook and Buy Rating for HCA Healthcare Driven by Strategic Initiatives and Market Dynamics
HCA Healthcare Price Target Cut to $355.00/Share From $406.00 by Morgan Stanley
HCA Healthcare Is Maintained at Equal-Weight by Morgan Stanley
Goldman Sachs Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $319
Morgan Stanley Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $355
HCA Healthcare Analyst Ratings
JP Morgan Assumes HCA Healthcare at Neutral, Announces Price Target of $380
Goldman Sachs Adjusts Price Target on HCA Healthcare to $319 From $359, Maintains Neutral Rating
HCA Healthcare (HCA) Was Downgraded to a Sell Rating at Wells Fargo
J.P. Morgan Maintains HCA Healthcare(HCA.US) With Hold Rating, Raises Target Price to $380
HCA Healthcare Cut to Underweight From Equal-Weight by Wells Fargo
Wells Fargo Downgrades HCA Healthcare(HCA.US) to Sell Rating, Cuts Target Price to $320